Similar Articles
711 Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
712 Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?
713 Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis
714 Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
715 Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
716 Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
717 Immunotherapy for hepatocellular carcinoma: Current and future
718 Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma
719 Hepatocellular carcinoma – time to take the ticket
720 Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA